These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6350137)

  • 1. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
    Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
    Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The behavior of glucose tolerance, serum insulin and C-peptide in acute viral hepatitis].
    Kelch L; Adlung J; Babaian E; Jaensch H
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(3):134-43. PubMed ID: 7021126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.
    Kaneko K; Arai M; Funatomi H; Hatta Y; Mitamura K
    J Gastroenterol; 1995 Oct; 30(5):624-31. PubMed ID: 8574335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spontaneous portal-systemic shunting on insulin metabolism.
    Smith-Laing G; Sherlock S; Faber OK
    Gastroenterology; 1979 Apr; 76(4):685-90. PubMed ID: 421995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin and C-peptide in chronic liver diseases during oral glucose tolerance testing].
    Oehler G; Knecht M; Bleyl H; Matthes KJ
    Dtsch Med Wochenschr; 1984 Feb; 109(7):253-7. PubMed ID: 6365504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive dog C-peptide level in the pancreatic vein.
    Kawanishi K; Nishina Y; Ishida T; Machida S; Yamamoto S; Ofuji T; Sakura N; Yanaihara N
    Horm Metab Res; 1980 Dec; 12(12):660-4. PubMed ID: 6162771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate metabolism and plasma levels of insulin and glucagon in patients with atherosclerotic vascular disease.
    Carreiro-Pousada JM; Garrote FJ; Rovira A; Herrera-Pombo JL; Valverde I
    Diabete Metab; 1988; 14(3):277-82. PubMed ID: 3044864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of carbohydrate-intolerant profiles of mothers with normal glucose tolerance tests and their large for gestational age neonates.
    Fukui R; Matsuzaki N; Fujita T; Kidoguchi K; Suehara N; Aono T
    Obstet Gynecol; 1995 Feb; 85(2):242-9. PubMed ID: 7824239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation and secretion of insulin in hepatic cirrhosis.
    Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
    J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma glucose, insulin and C-peptide responses in normal subjects to 100, 75 and 50 grams of glucose load during glucose tolerance test].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):648-50. PubMed ID: 6819874
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma insulin and C-peptide levels in cirrhotic and uremic patients.
    Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y
    Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of glucose intolerance and free fatty acid behavior in viral hepatitis.
    Granot C; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Jan; 17(1):12-8. PubMed ID: 7007283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.